Ref: Cao,G. unpublished

REBASE ref # 28456

Complete sequence: 4,379,573 bp

GenBank #: CP126335

REBASE acronym: PvuTAF3

Org_num: 68154

 

All begin QN092_

Type I
ORF Gene Most similar Specificity Name
 
14170 603 aa hypothetical protein
14175 R Mmo51TIP (96% identity) PvuTAF3ORF14190P
14180 AAA family ATPase
14185 S S.Mse9ORF8805P (51% identity) S.PvuTAF3ORF14190P
14190 M M.SchDC57ORF5385P (96% identity) M.PvuTAF3ORF14190P
14195 138 aa hypothetical protein
 
17845 187 aa hypothetical protein
17850 R SfrNORF1953P (98% identity) PvuTAF3ORF17865P
17855 Fic family protein
17860 S S.SspLC6ORF23440P (56% identity) S.PvuTAF3ORF17865P
17865 M M.Pre53ORF7100P (99% identity) M.PvuTAF3ORF17865P
17870 WYL domain-containing protein
Type II
ORF Gene Most similar Specificity Name
 
7245 conserved phage C-terminal domain-containing
7250 M M.PvuLs01ORF7715P (96% identity) M.PvuTAF3ORF7250P
7255 130 aa hypothetical protein
 
7285 64 aa hypothetical protein
7290 M M.PvuSC3ORF19165P (94% identity) M.PvuTAF3ORF7290P
7295 60 aa hypothetical protein
 
7805 DUF4060 family protein
7810 M M.Ppe12737ORF1370P (99% identity) M.PvuTAF3ORF7810P
7815 DUF2591 family protein
 
7870 50 aa hypothetical protein
7875 M M.PvuP3MORF6405P (89% identity) M.PvuTAF3ORF7875P
7880 87 aa hypothetical protein
 
13630 112 aa hypothetical protein
13635 M M.PvuTAF3ORF13935P (100% identity) YGGCCR M.PvuTAF3ORF13635P
13640 77 aa hypothetical protein
 
13930 112 aa hypothetical protein
13935 M M.PvuTAF3ORF13635P (100% identity) YGGCCR M.PvuTAF3ORF13935P
13940 77 aa hypothetical protein
Type IV
ORF Gene Most similar Specificity Name
 
9295 IS3 family transposase
9300 R PvuHJ90ORF9415P (99% identity) PvuTAF3ORF9300P
9305 (deoxy)nucleoside triphosphate
 
17255 thioredoxin family protein
17260 R PvuZN3McrCP (100% identity) PvuTAF3McrCP
17265 R PvuZN3McrBP (100% identity) PvuTAF3McrBP
17270 250 aa hypothetical protein
Tech Support Feedback NEB Overview Site Map Trademarks Legal and Disclaimers Privacy Cookie Policy Terms of Use
© Copyright 2023 New England Biolabs. All Rights Reserved.